Mission Statement

Oncology Business Review (OBR) is dedicated exclusively to the business of oncology. OBR provides instantaneous oncology news, provocative journalism, topical discussion, and a place to track performance of oncology products, companies, and people.





How Does Drug Pricing Drive Therapeutic Choice?


View the December 2007 webcast of this symposium sponsored by Biogen Idec.

  Biogen


The above presentations require the Adobe Flash plugin. If you do not have the plugin or have an older version, you may download it here.